Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial

Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial

The rates of pseudarthrosis remain high despite recent advances in bone graft substitutes for spinal fusion surgery. The aim of this single center, non-randomized, open-label clinical trial was to determine the feasibility of combined use of stromal vascular fraction (SVF) and β-tricalcium phosphate...

Full description

Bibliographic Details
Main Authors: Un Yong Choi, Kyoung-Tae Kim, Kwang Gi Kim, Sang Heon Lim, Young Jae Kim, Seil Sohn, Seung Hun Sheen, Chan Yeong Heo, Inbo Han
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cells
Subjects:
spinal stenosis
posterior lumbar interbody fusion
stromal vascular fraction
bone graft substitute
Online Access:https://www.mdpi.com/2073-4409/9/10/2250

Similar Items

Similar Items